18 results
6-K
EX-99.1
STVN
Stevanato Group Spa
2 Aug 23
Current report (foreign)
9:32am
.
Pharmaceutical innovation is driving advancements in more complex biologic drugs and paving the way for new therapies that address chronic diseases, co
6-K
EX-99.3
STVN
Stevanato Group Spa
24 May 23
Current report (foreign)
9:47am
, chronic obstructive pulmonary disease (COPD) and other respiratory-related diseases. Licensed from inhalation specialist, Iconovo, the device
6-K
EX-99.1
STVN
Stevanato Group Spa
10 Nov 22
Current report (foreign)
5:02pm
, such as the growth in biologics and biosimilars, the rise of chronic diseases, pharmaceutical innovation, and the self-administration of treatments.
We … , the increasing incidence of chronic disease, and the shift towards the self-administration of medicines.
Our customers are making groundbreaking strides
6-K
EX-99.1
STVN
Stevanato Group Spa
8 Nov 22
Current report (foreign)
6:53am
towards injectable delivery formats is boosted by favorable macro trends such as: growth in biologics and biosimilars rise of chronic disease pharmaceutical … in biologics and biosimilars dovetail with the macro trends of: aging populations, increasing incidence of chronic disease, and shift towards the self
6-K
EX-99.1
hzdhz5q
13 May 22
Stevanato Earnings Call
6:20am
6-K
EX-99.2
xo7bq2dw7s8
6 May 22
Ordinary and Extraordinary Shareholders’ Meeting
6:07am
20-F/A
h8suqcs9k7xnw sytt5
5 Apr 22
Annual report (foreign) (amended)
7:14am
6-K
EX-99.1
f1rvggruv2q2t 1xozyz
11 Mar 22
Current report (foreign)
6:59am
20-F
djsya 0b4kbl
8 Mar 22
Annual report (foreign)
6:50am
6-K
EX-99.1
v9lj60y 9qm3ywca
8 Mar 22
Current report (foreign)
6:44am
6-K
EX-99.1
xwr0p 4dhs
8 Mar 22
Stevanato Group Reports Record 2021 Revenue of €843.9 million
6:39am
424B4
x8y6i
16 Jul 21
Prospectus supplement with pricing info
2:18pm
F-1/A
1petzovoesi5d1nd
12 Jul 21
Registration statement (foreign) (amended)
7:22am
F-1/A
hcwfhjm
7 Jul 21
Registration statement (foreign) (amended)
9:59am
F-1
xytm16tew1djcz
21 Jun 21
Registration statement (foreign)
8:54am
DRS/A
7dqmdel8rgr71ew9
30 Apr 21
Draft registration statement (amended)
12:00am
DRS
mvn0wi0hdhe0uwjkxbee
22 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next